NCT05831709 The Influence of Hormone Replacement Therapy and Supervised Exercise Training on Body Composition, Cardiovascular Risk and Insulin Sensitivity in Postmenopausal Women
| NCT ID | NCT05831709 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Postmenopause |
| Study Type | INTERVENTIONAL |
| Enrollment | 390 participants |
| Start Date | 2023-05-12 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 390 participants in total. It began in 2023-05-12 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial investigates whether supervised training in combination with hormonal substitution therapy has an impact on body composition, cardiovascular risk, risk for dementia, osteoporosis and insulin sensitivity in postmenopausal women.
Eligibility Criteria
Inclusion Criteria: * Postmenopausal women (diagnosed by physician) with complaints due to menopause * Indication for hormonal substitution therapy (except for the control group) * Good general health * BMI: 20-30 kg/m2 * Only the use of cholesterol-, blood pressure- or/and thyroid-regulating medication is permitted
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05831709 clinical trial?
This trial is open to female participants only, aged 45 Years or older, up to 65 Years, studying Postmenopause. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05831709 currently recruiting?
Yes, NCT05831709 is actively recruiting participants. Contact the research team at studieco.vrouwenkliniek@uzgent.be for enrollment information.
Where is the NCT05831709 trial being conducted?
This trial is being conducted at Ghent, Belgium.
Who is sponsoring the NCT05831709 clinical trial?
NCT05831709 is sponsored by University Hospital, Ghent. The trial plans to enroll 390 participants.